As of December 15, 2025, Edwards Lifesciences Corp (EW) reports a Net Margin of 76.75%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Edwards Lifesciences Corp's Net Margin
Over recent years, Edwards Lifesciences Corp's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 76.75% |
| 2023-12-31 | 23.35% |
| 2022-12-31 | 28.28% |
| 2021-12-31 | 28.73% |
| 2020-12-31 | 18.77% |
This slight downward trend highlights how Edwards Lifesciences Corp manages its overall profitability and cost control over time.
Comparing Edwards Lifesciences Corp's Net Margin to Peers
To better understand Edwards Lifesciences Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Edwards Lifesciences Corp (EW) | 76.75% |
| Intuitive Surgical Inc (ISRG) | 27.81% |
| Resmed Inc (RMD) | 27.22% |
| Insulet Corp (PODD) | 20.19% |
| Shockwave Medical Inc (SWAV) | 20.17% |
| Dexcom Inc (DXCM) | 14.29% |
Compared to its competitors, Edwards Lifesciences Corp's Net Margin is higher than all peers, suggesting strong overall cost management and pricing power.